About us
Medical Center “Ģimenes Sirds”
“Ģimenes Sirds” means The Heart of the Family.
Founded in 2017, bringing together various specialists so that—with their professional skills—they can help conceive, carry and welcome each little one. We work with the family as one whole — father, mother, children — one heart.
Our main mission – to help couples with reduced fertility. So that, by identifying, correcting and treating fertility disorders, a couple can conceive their baby naturally without medical fertilization.
We also consult and train couples in fertility management, which allows the use of natural family-planning methods with high precision throughout life.
As well, we help to diagnose and treat various women’s health problems, from puberty to old age.
Our own values are rooted in the Word of God, and our professional work is based on these values, but we are open to helping anyone — believer or non-believer.
With the support of EU funds, we have implemented various projects for the convenience of our patients:
Digitalization project supported by the EU Recovery and Resilience Facility
Ģimenes sirds digitalization project
European Union Recovery and Resilience Facility,
is implementing a digitalization project aimed at improving business processes.
Within the project, a website with a new visual identity is being developed,
a patient e-booking system is being created, electronically fillable patient questionnaires
(health self-assessment forms) are being implemented, and an e-commerce store is being established.
As a result of the project, the company’s internal processes are improved,
and modern, digitally accessible patient services are ensured.
Project duration and contract
Project duration: 15.01.2025 – 15.01.2026
Project contract: Nr.9.2-17-L-2025/24
Project ENTER
Project ENTER: Innovative prenatal care and consulting
Project ENTER is a significant step in improving prenatal care by offering a vision for more accessible, cost-effective and higher-quality services for expectant mothers in Latvia. It emphasises non-invasive prenatal screening/testing (NIPT).
Within Project ENTER, four organisations — the Health Technology Competence Centre in Estonia, the Latvian laboratory “GenEra”, and the clinics “Family Heart” and “Dubultu Doctorate” — have joined forces to provide quality prenatal care and consulting using modern genetics and digital technology.
Goals: The main goals include building modern digital data-exchange and online consultation systems, while validating their effectiveness via a study with 300 patients.
Using the existing Estonian NIPT service (NIPTIFY), ENTER aims to provide testing opportunities to providers in Vidzeme, the Riga region and other cross-border Estonia–Latvia regions, thereby improving prenatal-care quality.
In Latvia approximately 16,000 births are registered each year, of which 15% require NIPT due to the risk of fetal chromosomal disorders. However, testing availability and cost are critical. Current high test costs and lack of interpretation expertise limit patient access to these important services.
Collaboration with the Estonian biotechnology company CCHT, which successfully introduced NIPTIFY, promises to deliver significant support, enabling comprehensive service provision. By sharing experience across regions, private clinics can offer genetic services without needing full expert competency in each region. ENTER intends to break away from the dominant structures, thereby improving quality and accessibility by integrating digital, genetic and clinical competence.
Funding: The project’s total funding is €607,700, with 80% financed under the Estonia–Latvia Interreg 2021-2027 programme.
Period: The project is planned from 1 October 2023 to 30 September 2026.
Here is the report on the Interreg VI‑A Estonia‑Latvia Programme 2021‑2027.
What is NIPT?
NIPT (Non-Invasive Prenatal Testing) is an additional genetic screening test that provides a more accurate assessment of chromosomal risk.
- NIPT is used as a screening test to assess the risk of genetic conditions in order to avoid unnecessary invasive procedures that may potentially endanger the pregnancy.
- NIPT results cannot be considered diagnostic, as the test analyzes placental genetic material present in the mother’s blood, which in rare cases (less than 2%) may differ from the genetic material of the fetus.
- Therefore, if the NIPT result indicates a high risk, an invasive DNA test must be performed to confirm the findings.